Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 19, Issue 7, 2013, Pages 1068-1078

  Feng, Fan ^a,b   Lu, Yin Ying ^a   Zhang, Fan ^c   Gao, Xu Dong ^a   Zhang, Chuan Fu ^b   Meredith, Alex ^d   Xu, Zhong Xian ^a   Yang, Yu Tao ^e   Chang, Xiu Juan ^a   Wang, Hong ^a   Qu, Jian Hui ^a   Zeng, Zhen ^a   Yang, Jun Lan ^c   Wang, Chun Ping ^a   Zhu, Yun Feng ^c   Cui, Jia Jun ^b,d   Yang, Yong Ping ^a  

^a 302 MILITARY HOSPITAL   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapeutic drugs; Hepatocellular carcinoma; Long interspersed nuclear element 1 ORF 1 protein; Multi drug resistance

Indexed keywords

CISPLATIN; EPIRUBICIN; LINE 1 PROTEIN; LUCIFERASE; NUCLEAR PROTEIN; ORF 1 PROTEIN; PACLITAXEL; PROTEIN BCL 2; PROTEIN P15; PROTEIN P27; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84874356632     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i7.1068     Document Type: Article

References (22)

1. Guo XL, Li D, Hu F, Song JR, Zhang SS, Deng WJ, Sun K, Zhao QD, Xie XQ, Song YJ, Wu MC, Wei LX. Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett 2012; 320: 171-179. [PMID: 22406827 DOI: 10.1016/ j.canlet.2012.03.002]
2. Lee JH, Chung YH, Kim JA, Shim JH, Lee D, Lee HC, Shin ES, Yoon JH, Kim BI, Bae SH, Koh KC, Park NH. Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma. Cancer 2013; 119: 136-142. [PMID: 22736425 DOI: 10.1002/cncr.27705]
3. Sauer G, Kafka A, Grundmann R, Kreienberg R, Zeillinger R, Deissler H. Basal expression of the multidrug resistance gene 1 (MDR-1) is associated with the TT genotype at the polymorphic site C3435T in mammary and ovarian carcinoma cell lines. Cancer Lett 2002; 185: 79-85. [PMID: 12142082 DOI: 10.1016/S0304-3835(02)00232-X]
4. Goodier JL, Zhang L, Vetter MR, Kazazian HH. LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol Cell Biol 2007; 27: 6469-6483. [PMID: 17562864 DOI: 10.1128/MCB.00332-07]
5. Evans JD, Peddigari S, Chaurasiya KR, Williams MC, Martin SL. Paired mutations abolish and restore the balanced annealing and melting activities of ORF1p that are required for LINE-1 retrotransposition. Nucleic Acids Res 2011; 39: 5611-5621. [PMID: 21441536 DOI: 10.1093/nar/gkr171]
6. Gao XD, Hu M, Zhu Y. The down-regulation of LINE-1 encoded ORF-1p impacts the characters of A549 cells. Zhongguo Shengwu Kexue Zazhi 2010; 30: 14-20
7. Fan F, Gao XD, Lu YY, Zhang F, Wang B, Chang XJ, Qu JH, Wang CP, Yang YP. Regulatory effect of LINE-1 ORF-1p on hepatocellular carcinoma cells and proliferation of immortalized hepatocellular cells. Jiefangjun Yixue Zazhi 2012; 37: 213-216
8. Sunami E, de Maat M, Vu A, Turner RR, Hoon DS. LINE-1 hypomethylation during primary colon cancer progression. PLoS One 2011; 6: e18884. [PMID: 21533144 DOI: 10.1371/ journal.pone.0018884]
9. Beck CR, Garcia-Perez JL, Badge RM, Moran JV. LINE-1 elements in structural variation and disease. Annu Rev Genomics Hum Genet 2011; 12: 187-215. [PMID: 21801021 DOI: 10.1146/annurev-genom-082509-141802]
10. Ohka F, Natsume A, Motomura K, Kishida Y, Kondo Y, Abe T, Nakasu Y, Namba H, Wakai K, Fukui T, Momota H, Iwami K, Kinjo S, Ito M, Fujii M, Wakabayashi T. The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. PLoS One 2011; 6: e23332. [PMID: 21829728 DOI: 10.1371/journal.pone.0023332]
11. Ramzy II, Omran DA, Hamad O, Shaker O, Abboud A. Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma. Arab J Gastroenterol 2011; 12: 139-142. [PMID: 22055592]
12. Hu MM, Zhu YF, Wang Y, Wang Y, Zhang L, Gao XD, Dong J, Yu JY. Prokaryotic expression of LINE-1 encoded protein LINE-1 ORF-1p and preparation of anti-LINE-1 ORF-1p antibody. Zhongguo Shengwu Kexue Zazhi 2010; 30: 7-10
13. Pivonková H, Pecinka P, Cesková P, Fojta M. DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner. FEBS J 2006; 273: 4693-4706. [PMID: 16981908 DOI: 10.1111/j.1742-4658.2006.05472.x]
14. Gao XD. Master degree thesis, Academy of Military Medical Science, PR China, 2010
15. Gao XD, Lu YY, Feng F, Wang CP, Wang H, Chang XJ, Yang YP. Effects of LINE-1 ORF-1p overexpression on proliferation and anchorindependent growth of SMMC7721 hepatoma cell line. Shiyong Ganzangbing Zazhi 2011; 14: 323-326
16. Chanel-Vos C, Giannakakou P. CENP-E checks in microtubule-drug resistance. Cell Cycle 2010; 9: 1456. [PMID: 20421712 DOI: 10.4161/cc.9.8.11382]
17. Yan J, Fang Y, Ding L, Zhu J, Lu Q, Huang C, Yang X, Ye Q. Regulation of large-scale chromatin unfolding by Smad4. Biochem Biophys Res Commun 2004; 315: 330-335. [PMID: 14766211 DOI: 10.1016/j.bbrc.2004.01.051]
18. Zhang F, Feng F, Yang PX, Li ZJ, You JH, Xie WX, Gao XD, Yang JL. Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell. Int J Biochem Cell Biol 2012; 44: 320-326. [PMID: 22094188]
19. Tolomeo M, Grimaudo S, Di Cristina A, Roberti M, Pizzirani D, Meli M, Dusonchet L, Gebbia N, Abbadessa V, Crosta L, Barucchello R, Grisolia G, Invidiata F, Simoni D. Pterostilbene and 3'-hydroxypterostilbene are effective apoptosisinducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 2005; 37: 1709-1726. [PMID: 15878840 DOI: 10.1016/j.biocel.2005.03.004]
20. Qin Q, Chen XP, Yang ZS, Xiao YH, Min H, Li YJ. Neferine increases STI571 chemosensitivity via inhibition of P-gp expression in STI571-resistant K562 cells. Leuk Lymphoma 2011; 52: 694-700. [PMID: 21261505 DOI: 10.3109/10428194.2010.55 0075]
21. Choi WI, Jeon BN, Yun CO, Kim PH, Kim SE, Choi KY, Kim SH, Hur MW. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J Biol Chem 2009; 284: 12633-12644. [PMID: 19244234 DOI: 10.1074/jbc.M809794200]
22. Cui J, Germer K, Wu T, Wang J, Luo J, Wang SC, Wang Q, Zhang X. Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells. Cancer Res 2012; 72: 5625-5634. [PMID: 22964581 DOI: 10.1158/0008-5472. CAN-12-1305]